PAIGE ANDERSON: Open Payments
NPI 1285116020 · SAN LEANDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $75 |
| Ardelyx, Inc. | 2 | $52 |
| Janssen Biotech, Inc. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Medtronic, Inc. | 1 | $16 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, ENTYVIO, XIFAXAN, AQUAMANTYS(TM).
Industry payments across CA — which companies pay providers there.
